Obesity Today: Chugai licenses CT-388 for Japan, GLP-1 access news (Oct 7–14, 2025)
Obesity news this week include Chugai in-licensing Roche’s dual incretin CT-388…
Obesity news this week include Chugai in-licensing Roche’s dual incretin CT-388…
We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".